2024 POC Infectious Disease Diagnostics Forecasts for 100 Tests, 2023 Supplier Shares: Physician Offices, ER, OR, ICU, Ambulatory, Surgery and Birth Centers--Instrumentation Review, Emerging Technologies

This new report provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market.

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

• Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
• Five-year test volume and reagent sales forecasts for hematology and flow cytometry procedures by market segment:
• Physician Offices/Group Practices
• Emergency Rooms
• Operating/Recovery Suites
• ICUs/CCUs
• Cancer Clinics
• Ambulatory Care Centers
• Surgery Centers
• Nursing Homes
• Birth Centers

Sales and Market Share Analysis

• Sales and market shares of major hematology and flow cytometry reagent and instrument suppliers.

Instrument Placements and Installed Base

• The report provides estimates of annual placements and total installed base for major hematology and flow cytometry analyzers.

Current and Emerging Products

• Analysis of hematology and flow cytometry procedures performed in POC testing locations.
• Review of leading hematology and flow cytometry analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.

Technology Review

• Emerging technologies and their applications for POC testing.- Comprehensive listings of companies developing or marketing hematology and flow cytometry testing technologies and products, by assay.

Competitive Assessments

• Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

• Specific opportunities for new hematology and flow cytometry instruments and reagent systems with potentially significant market appeal during the next five years.
• Design criteria for POC testing products.
• Alternative business expansion strategies.
• Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and the publisher's proprietary data files. This report provides a comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation

• Review of the POC clinical chemistry and immunodiagnostic market segments, including their dynamics, trends, structure, size, growth and major suppliers.
• Five-year test volume and reagent sales forecasts clinical chemistry procedures by market segment:
• Physician Offices/Group Practices
• Emergency Rooms
• Operating/Recovery Suites
• ICUs/CCUs
• Cancer Clinics
• Ambulatory Care Centers
• Surgery Centers
• Nursing Homes
• Birth Centers

Sales and Market Share Analysis

• Sales and market shares ofmajor reagent and instrument suppliers.

Routine Clinical Chemistry Tests

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Blood Gases, BUN (Blood Urea Nitrogen), Calcium, Cholesterol, Cholinesterase, Creatinine, CK-MB, Electrolytes (Carbon Dioxide/Bicarbonate, Chloride, Potassium, Sodium), Ferritin, Follate/Folic Acid, Fructosamine, GGT, Glucose, HDL, Iron, LDH, Magnesium, Phosphorus, Potassium, Protein, Sodium, Triglycerides, Troponin, Uric Acid, Urinalysis, Vitamin B12.

Endocrine Function Tests

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, TSH.

Therapeutic Drug Monitoring (TDM) Tests

Amikacin, Carbamazepine, Digoxin, Gentamicin, Lidocaine, Lithium, Methotrexate, Phenobarbital, Phenytoin/Dilatin, NAPA/Procainamide, Quinidine, Theophylline, Tobramycin, Valproic Acid, Vancomycin.

Immunoprotein Tests

C3, C4, CRP, IgA, IgE Specific, IgE Total, IgG, Immunoglobulins, Protein Electrophoresis, and others.

Drugs of Abuse

Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine, Propoxyphene, and others.

Technology Review

• Emerging technologies and their applications for POC testing.

Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Strategic Recommendations

• Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.
• Design criteria for POC testing products.
• Alternative business expansion strategies.
• Potential market entry barriers and risks.

Competitive Assessments

• Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
• The companies analyzed in the report include:
• Abbott Laboratories
• Agilent Technologies
• Beckman Coulter/Danaher
• bioMerieux
• Bio-Rad
• DiaSorin
• Eiken Chemical
• Fujifilm Wako
• Fujirebio
• Grifols
• Instrumentation Laboratory/Werfen
• Kyowa Medex
• PerkinElmer
• Quest Diagnostics
• QuidelOrtho
• Roche
• Siemens Healthineers
• Sysmex
• Thermo Fisher
• Tosoh

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and the publisher's proprietary data files.